The micro(nano)plastics perspective: exploring cancer development and therapy

Abstract Microplastics, as an emerging environmental pollutant, have received widespread attention for their potential impact on ecosystems and human health. Microplastics are defined as plastic particles less than 5 millimeters in diameter and can be categorized as primary and secondary microplasti...

Full description

Saved in:
Bibliographic Details
Main Authors: Xiangying Deng, Yajun Gui, Lin Zhao
Format: Article
Language:English
Published: BMC 2025-01-01
Series:Molecular Cancer
Subjects:
Online Access:https://doi.org/10.1186/s12943-025-02230-z
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832585966651441152
author Xiangying Deng
Yajun Gui
Lin Zhao
author_facet Xiangying Deng
Yajun Gui
Lin Zhao
author_sort Xiangying Deng
collection DOAJ
description Abstract Microplastics, as an emerging environmental pollutant, have received widespread attention for their potential impact on ecosystems and human health. Microplastics are defined as plastic particles less than 5 millimeters in diameter and can be categorized as primary and secondary microplastics. Primary microplastics usually originate directly from industrial production, while secondary microplastics are formed by the degradation of larger plastic items. Microplastics are capable of triggering cytotoxicity and chronic inflammation, and may promote cancer through mechanisms such as pro-inflammatory responses, oxidative stress and endocrine disruption. In addition, improved microplastics bring new perspectives to cancer therapy, and studies of microplastics as drug carriers are underway, showing potential for high targeting and bioavailability. Although current studies suggest an association between microplastics and certain cancers (e.g., lung, liver, and breast cancers), the long-term effects and specific mechanisms still need to be studied. This review aimed at exploring the carcinogenicity of microplastics and their promising applications in cancer therapy provides important directions for future research and emphasizes the need for multidisciplinary collaboration to address this global health challenge.
format Article
id doaj-art-13b6cfba79bb417f9906695585fd6b97
institution Kabale University
issn 1476-4598
language English
publishDate 2025-01-01
publisher BMC
record_format Article
series Molecular Cancer
spelling doaj-art-13b6cfba79bb417f9906695585fd6b972025-01-26T12:18:15ZengBMCMolecular Cancer1476-45982025-01-0124111410.1186/s12943-025-02230-zThe micro(nano)plastics perspective: exploring cancer development and therapyXiangying Deng0Yajun Gui1Lin Zhao2Department of Pathology, The Second Xiangya Hospital, Central South UniversityDepartment of Pathology, The Second Xiangya Hospital, Central South UniversityDepartment of Pathology, The Second Xiangya Hospital, Central South UniversityAbstract Microplastics, as an emerging environmental pollutant, have received widespread attention for their potential impact on ecosystems and human health. Microplastics are defined as plastic particles less than 5 millimeters in diameter and can be categorized as primary and secondary microplastics. Primary microplastics usually originate directly from industrial production, while secondary microplastics are formed by the degradation of larger plastic items. Microplastics are capable of triggering cytotoxicity and chronic inflammation, and may promote cancer through mechanisms such as pro-inflammatory responses, oxidative stress and endocrine disruption. In addition, improved microplastics bring new perspectives to cancer therapy, and studies of microplastics as drug carriers are underway, showing potential for high targeting and bioavailability. Although current studies suggest an association between microplastics and certain cancers (e.g., lung, liver, and breast cancers), the long-term effects and specific mechanisms still need to be studied. This review aimed at exploring the carcinogenicity of microplastics and their promising applications in cancer therapy provides important directions for future research and emphasizes the need for multidisciplinary collaboration to address this global health challenge.https://doi.org/10.1186/s12943-025-02230-zMicro (nano) plasticsCarcinogenicityDrug carrierCancer therapy
spellingShingle Xiangying Deng
Yajun Gui
Lin Zhao
The micro(nano)plastics perspective: exploring cancer development and therapy
Molecular Cancer
Micro (nano) plastics
Carcinogenicity
Drug carrier
Cancer therapy
title The micro(nano)plastics perspective: exploring cancer development and therapy
title_full The micro(nano)plastics perspective: exploring cancer development and therapy
title_fullStr The micro(nano)plastics perspective: exploring cancer development and therapy
title_full_unstemmed The micro(nano)plastics perspective: exploring cancer development and therapy
title_short The micro(nano)plastics perspective: exploring cancer development and therapy
title_sort micro nano plastics perspective exploring cancer development and therapy
topic Micro (nano) plastics
Carcinogenicity
Drug carrier
Cancer therapy
url https://doi.org/10.1186/s12943-025-02230-z
work_keys_str_mv AT xiangyingdeng themicronanoplasticsperspectiveexploringcancerdevelopmentandtherapy
AT yajungui themicronanoplasticsperspectiveexploringcancerdevelopmentandtherapy
AT linzhao themicronanoplasticsperspectiveexploringcancerdevelopmentandtherapy
AT xiangyingdeng micronanoplasticsperspectiveexploringcancerdevelopmentandtherapy
AT yajungui micronanoplasticsperspectiveexploringcancerdevelopmentandtherapy
AT linzhao micronanoplasticsperspectiveexploringcancerdevelopmentandtherapy